Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness

Feasibility and Preliminary Effectiveness of HABIT-ILE + Functional Strength Training in Children With Spinal Muscular Atrophy (SMA): a Prospective Single-group Intervention Trial.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This single-arm pilot study will assess the preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend a HABIT-ILE + FST summer camp for 6 hours per day over a 3-week period, totaling 90 hours of training.

Who May Be Eligible (Plain English)

Who May Qualify: - Have a confirmed SMA diagnosis - Be 5-17 years old - Complete all pre- and post-intervention assessments - Understand and speak English - Follow instructions without major cognitive or behavioral issues - Have received a stable disease-modifying therapy (DMT) dose for ≥6 months - Be classified as a sitter or walker (SMA type 2 or 3) with supported standing ability (score ≥1 on Item 18 of the HFMSE) without KAFOs, AFOs, or external standing devices Who Should NOT Join This Trial: - Orthopedic surgery within the past year - New pharmaceutical treatment during the study - Concurrent participation in another clinical trial Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Have a confirmed SMA diagnosis * Be 5-17 years old * Complete all pre- and post-intervention assessments * Understand and speak English * Follow instructions without major cognitive or behavioral issues * Have received a stable disease-modifying therapy (DMT) dose for ≥6 months * Be classified as a sitter or walker (SMA type 2 or 3) with supported standing ability (score ≥1 on Item 18 of the HFMSE) without KAFOs, AFOs, or external standing devices Exclusion Criteria: * Orthopedic surgery within the past year * New pharmaceutical treatment during the study * Concurrent participation in another clinical trial

Treatments Being Tested

OTHER

Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST)

Goal-directed, task-specific training for both the upper and lower extremity, and postural control with targeted strengthening exercises to enhance motor control and facilitate the achievement of functional goals

Locations (1)

Center for Cerebral Palsy Research, Teachers College, Columbia University
New York, New York, United States